Embark Veterinary, Inc. is a company that specializes in canine genetics. It provides comprehensive DNA testing for dogs to help owners, breeders, and veterinarians understand dog breeds, ancestry, health, and traits. The company leverages research-grade technology to deliver detailed insights into a dog's genetic makeup.

Embark Veterinary, Inc.

Embark Ventures is a Los Angeles based venture capital firm focused on early-stage investments. We are particularly interested in frontier/deep tech where technology creates a defensible competitive advantage. Specific areas of interest include Fintech, cybersecurity, AI, machine learning, robotics, and emerging platforms such as voice, blockchain, and autonomous vehicles.  We have a particular interest in Southern California companies but invest nationally.

msh id	VC:EMBARK
symbol	-
name	Embark Veterinary, Inc.
homepage url	https://embark.vc
country	US
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	2
crunchbase url	https://www.crunchbase.com/organization/embark-veterinary
linkedin url	https://www.linkedin.com/company/embark-ventures
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	24.42
growth score 28	29.84
growth score 90	25.24
growth score 365	19.53

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

VC:EMBARK

Embark Veterinary, Inc.

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-